ArticleEmerging infectious diseases2016
Multidrug-Resistant Staphylococcus aureus, India, 2013-2015.
Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates.Antimicrobial resistance and infection control · 2021Pooled it
- Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.Scientific reports · 2020Pooled it
- Identification of quinoline scaffolds against emerging drug target glycerophosphodiester phosphodiesterase fromRSC advances · 2026Article
- Genomic characterization of healthcare-associated ST5 MRSA causing severe pseudomembranous enteritis in intensive care unit.BMC infectious diseases · 2025Article
- Bibliometric analysis of hotspots inFrontiers in microbiology · 2025Article
- Antibiotic Resistance Profile ofBioMed research international · 2024Article
- Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance.Microbiology spectrum · 2023Article
- A cross-sectional study on the prevalence and drug susceptibility pattern of methicillin-resistantThe Pan African medical journal · 2023Article
- MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives.Antibiotics (Basel, Switzerland) · 2022Article
- 7,8-Dihydroxyflavone attenuates the virulence of Staphylococcus aureus by inhibiting alpha-hemolysin.World journal of microbiology & biotechnology · 2022Article
- The Prevalence and Antimicrobial Susceptibility Pattern of Gram-Positive Pathogens: Three-Year Study at a Tertiary Care Hospital in Mumbai, India.Journal of laboratory physicians · 2022Article
- Theragnostic application of nanoparticle and CRISPR against food-borne multi-drug resistant pathogens.Materials today. Bio · 2022Review
- Early Warning and Clinical Epidemiological Characteristics of Lung Injury in the Treatment of InfectiousComputational intelligence and neuroscience · 2022Article
- Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin ResistantMolecules (Basel, Switzerland) · 2021Article
- Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-ResistantFrontiers in microbiology · 2021Article
- A Systemic Literature Review and Meta-Analysis Reporting the Prevalence and Impact of Methicillin-ResistantInfectious diseases · 2020Article
- Prevalence, Characterization, and Drug Resistance ofFrontiers in medicine · 2020Article
- Using genomics to understand meticillin- and vancomycin-resistantMicrobial genomics · 2020Review
- Current trends in targeted therapy for drug-resistant infections.Applied microbiology and biotechnology · 2019Review
- Methicillin-resistant Staphylococcus aureus (MRSA) in East Africa: red alert or red herring?BMC infectious diseases · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.